HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazunori Shimada Selected Research

8,11,14-Eicosatrienoic Acid (Dihomo-gamma-Linolenic Acid)

1/2018Impact of smoking history on the association between Eicosapentaenoic acid to arachidonic acid ratio and acute coronary syndrome: A multicenter cross-sectional study.
8/2017Low Docosahexaenoic Acid, Dihomo-Gamma-Linolenic Acid, and Arachidonic Acid Levels Associated with Long-Term Mortality in Patients with Acute Decompensated Heart Failure in Different Nutritional Statuses.
8/2017Decreased circulating dihomo-gamma-linolenic acid levels are associated with total mortality in patients with acute cardiovascular disease and acute decompensated heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazunori Shimada Research Topics

Disease

25Coronary Artery Disease (Coronary Atherosclerosis)
08/2021 - 03/2002
20Acute Coronary Syndrome
11/2020 - 05/2004
19Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2004
14Inflammation (Inflammations)
01/2021 - 04/2005
14Atherosclerosis
06/2020 - 01/2003
12Insulin Resistance
01/2021 - 06/2004
11Heart Failure
01/2022 - 10/2009
7Diabetes Mellitus
10/2021 - 09/2011
7Hypertension (High Blood Pressure)
04/2021 - 04/2014
7Neoplasms (Cancer)
01/2020 - 01/2009
7Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2017 - 02/2008
5Frailty
11/2021 - 01/2019
5Atherosclerotic Plaque (Atheroma)
05/2020 - 03/2009
4Chronic Renal Insufficiency
10/2021 - 09/2012
4Hyperglycemia
01/2019 - 07/2010
4Type 2 Diabetes Mellitus (MODY)
01/2018 - 06/2004
3Myocardial Infarction
01/2020 - 10/2009
3Stable Angina
11/2014 - 01/2003
2Atrial Fibrillation
11/2021 - 06/2017
2Dyslipidemias (Dyslipidemia)
04/2021 - 01/2017
2Critical Illness (Critically Ill)
03/2021 - 06/2017
2Fibrosis (Cirrhosis)
01/2021 - 01/2020
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 11/2008
2Hyperinsulinism (Hyperinsulinemia)
10/2019 - 01/2017
2Coronary Disease (Coronary Heart Disease)
12/2018 - 07/2010
2Body Weight (Weight, Body)
01/2018 - 09/2011
2Obesity
07/2017 - 06/2004
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
04/2014 - 05/2013
2Stomach Neoplasms (Stomach Cancer)
03/2014 - 04/2009
1Sarcopenia
11/2021
1Atrial Remodeling
11/2021
1Amyloidosis
10/2021
1Constipation
06/2021
1Rheumatoid Arthritis
04/2021
1ST Elevation Myocardial Infarction
11/2020
1Non-ST Elevated Myocardial Infarction
11/2020
1Autoimmune Diseases (Autoimmune Disease)
06/2020

Drug/Important Bio-Agent (IBA)

10Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2020 - 02/2014
9Glucose (Dextrose)FDA LinkGeneric
07/2020 - 02/2008
9oxidized low density lipoproteinIBA
05/2020 - 03/2004
8LipidsIBA
11/2020 - 08/2004
7Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2013
7Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2020 - 08/2004
7Biomarkers (Surrogate Marker)IBA
07/2019 - 05/2011
7Lipoproteins (Lipoprotein)IBA
04/2014 - 01/2003
6Insulin (Novolin)FDA Link
07/2020 - 02/2008
6LDL Receptors (LDL Receptor)IBA
05/2020 - 05/2013
6Eicosapentaenoic AcidIBA
07/2018 - 01/2016
6Docosahexaenoic AcidsIBA
07/2018 - 01/2016
5C-Reactive ProteinIBA
04/2020 - 01/2003
5omega-Chloroacetophenone (Mace)IBA
04/2020 - 04/2010
5Arachidonic Acid (Vitamin F)IBA
07/2018 - 01/2016
4AdiponectinIBA
01/2021 - 03/2002
3HDL CholesterolIBA
11/2021 - 12/2018
3CholesterolIBA
11/2021 - 03/2015
3Oxygen (Dioxygen)IBA
04/2021 - 08/2018
3CytokinesIBA
01/2021 - 04/2005
3InterleukinsIBA
01/2021 - 01/2003
3LDL CholesterolIBA
05/2020 - 01/2018
3LDL Lipoproteins (beta Lipoproteins)IBA
06/2019 - 03/2005
31,5-anhydroglucitolIBA
01/2019 - 10/2016
38,11,14-Eicosatrienoic Acid (Dihomo-gamma-Linolenic Acid)IBA
01/2018 - 08/2017
3Fatty Acids (Saturated Fatty Acids)IBA
04/2014 - 05/2008
2Syntex adjuvant formulationIBA
10/2021 - 01/2020
2Advanced Glycation End ProductsIBA
10/2021 - 01/2020
2Hemoglobins (Hemoglobin)IBA
06/2021 - 11/2017
2AlbuminsIBA
06/2021 - 04/2014
2coenzyme Q10 (CoQ10)IBA
03/2021 - 06/2017
2ApolipoproteinsIBA
06/2020 - 03/2009
2Interleukin-6 (Interleukin 6)IBA
01/2020 - 05/2016
2Biological ProductsIBA
10/2017 - 02/2008
2pro-brain natriuretic peptide (1-76)IBA
08/2017 - 05/2011
2Brain Natriuretic Peptide (Natrecor)FDA Link
08/2017 - 05/2011
2Antihypertensive Agents (Antihypertensives)IBA
06/2017 - 01/2015
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2015 - 09/2011
2azelnidipineIBA
01/2015 - 09/2011
2hexacosanoic acidIBA
04/2014 - 05/2008
2lysophosphatidic acidIBA
07/2013 - 01/2012
2Toll-Like Receptors (Toll-Like Receptor)IBA
03/2008 - 09/2005
2Interleukin-18 (Interleukin 18)IBA
04/2005 - 01/2003
1iodofiltic acidIBA
01/2022
1pentadecanoic acidIBA
01/2022
1Indicators and Reagents (Reagents)IBA
11/2021
1HDL LipoproteinsIBA
11/2021
1Prealbumin (Transthyretin)IBA
10/2021
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
08/2021
1Influenza Vaccines (Influenza Vaccine)FDA Link
08/2021
123-valent pneumococcal capsular polysaccharide vaccineIBA
08/2021
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Apolipoproteins E (ApoE)IBA
06/2020
1Pharmaceutical PreparationsIBA
06/2020

Therapy/Procedure

14Cardiac Rehabilitation
10/2021 - 01/2003
8Therapeutics
06/2020 - 01/2007
7Percutaneous Coronary Intervention
04/2021 - 01/2013
4Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2021 - 06/2009
3Drug Therapy (Chemotherapy)
06/2009 - 11/2008
2Catheter Ablation
11/2021 - 06/2017
2Stents
11/2017 - 10/2010
2Pancreas Transplantation
04/2008 - 01/2007